365
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Development of freeze-drying cycle via design space approach: a case study on vaccines

Pages 1302-1313 | Received 13 Mar 2020, Accepted 03 Aug 2020, Published online: 30 Aug 2020

References

  • Food and Drug Administration. 2009. ICH harmonised tripartite guideline pharmaceutical development Q8(R2). Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
  • Arsiccio A, Barresi AA, Pisano R. 2017. Prediction of ice crystal size distribution after freezing of pharmaceutical solutions. Crystal Growth Design. 17:4573–4581.
  • Arsiccio A, Giorsello P, Marenco L, Pisano R. 2020. Considerations on protein stability during freezing and its impact on the freeze-drying cycle: a design space approach. J Pharm Sci. 109:464–475.
  • Arsiccio A, Pisano R. 2018. Application of the quality by design approach to the freezing step of freeze-drying: building the design space. J Pharm Sci. 107:1586–1596.
  • Arsiccio A, Sparavigna AC, Pisano R, Barresi AA. 2019. Measuring and predicting pore size distribution of freeze-dried solutions. Drying Technol. 37:435–447.
  • Beech KE, Biddlecombe JG, Van Der Walle CF, Stevens LA, Rigby SP, Burley JC, Allen S. 2015. Insights into the influence of the cooling profile on the reconstitution times of amorphous lyophilized protein formulations. Eur J Pharm Biopharm. 96:247–254.
  • Bourlès E, de Lannoy G, Scutellà B, Fonseca F, Trelea IC, Passot S. 2019. Scale-up of freeze-drying cycles, the use of process analytical technology (PAT), and statistical analysis. In: Ward KR, Matejtschuk P, editor. Lyophilization of pharmaceuticals and biologicals. Methods in pharmacology and toxicology. New York (NY): Humana Press; p. 215–240.
  • Box GEP, Hunter JS, Hunter WG. 2005. Statistics for experimenters. 2nd ed. Hoboken (NJ): Wiley.
  • Chang BS, Fischer NL. 1995. Development of an efficient single-step freeze-drying cycle for protein formulations. Pharm Res. 12:831–837.
  • Fissore D, Barresi AA. 2011. Scale-up and process transfer of freeze-drying recipes. Drying Technol. 29:1673–1684.
  • Fissore D, Pisano R. 2015. Computer-aided framework for the design of freeze-drying cycles: optimization of the operating conditions of the primary drying stage. Processes. 3:406–421.
  • Fissore D, Pisano R, Barresi AA. 2011a. On the methods based on the pressure rise test for monitoring a freeze-drying process. Drying Technol. 29:73–90.
  • Fissore D, Pisano R, Barresi AA. 2011b. Advanced approach to build the design space for the primary drying of a pharmaceutical freeze-drying process. J Pharm Sci. 100:4922–4933.
  • Giordano A, Barresi AA, Fissore D. 2011. On the use of mathematical models to build the design space for the primary drying phase of a pharmaceutical lyophilization process. J Pharm Sci. 100:311–324.
  • Hansen LJJ, Daoussi R, Vervaet C, Remon JP, De Beer TRM. 2015. Freeze-drying of live virus vaccines: a review. Vaccine. 33:5507–5519.
  • Kasper JC, Friess W. 2011. The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. Eur J Pharm Biopharm. 78:248–263.
  • Kodama T, Sawada H, Hosomi H, Takeuchi M, Wakiyama N, Yonemochi E, Terada K. 2013. Determination for dry layer resistance of sucrose under various primary drying conditions using a novel simulation program for designing pharmaceutical lyophilization cycle. Int J Pharm. 452:180–187.
  • Koganti VR, Shalaev EY, Berry MR, Osterberg T, Youssef M, Hiebert DN, Kanka FA, Nolan M, Barrett R, Scalzo G, et al. 2011. Investigation of design space for freeze-drying: use of modeling for primary drying segment of a freeze-drying cycle. AAPS PharmSciTech. 12:854–861.
  • Kulkarni SS, Suryanarayanan R, Rinella JV, Bogner RH. 2018. Mechanisms by which crystalline mannitol improves the reconstitution time of high concentration lyophilized protein formulations. Eur J Pharm Biopharm. 131:70–81.
  • Kuu WY, Hardwick LM, Akers MJ. 2006. Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles. Int J Pharm. 313:99–113.
  • Matejtschuk P, Malik K, Duru C. 2019. Formulation and process development for lyophilized biological reference materials. In: Ward KR, Matejtschuk P, editor. Lyophilization of pharmaceuticals and biologicals. Methods in pharmacology and toxicology. New York (NY): Humana Press; p. 33–55.
  • Mockus LN, Paul TW, Pease NA, Harper NJ, Basu PK, Oslos EA, Sacha GA, Kuu WY, Hardwick LM, Karty JJ, et al. 2011. Quality by design in formulation and process development for a freeze-dried, small molecule parenteral product: a case study. Pharm Dev Technol. 16:549–576.
  • Nail SL, Searles JA. 2008. Elements of quality by design in development and scale-up of freeze-dried parenterals. BioPharm International. 21:44–52.
  • Oddone I, Arsiccio A, Duru C, Malik K, Ferguson J, Pisano R, Matejtschuk P. 2020. Vacuum-induced surface freezing for the freeze-drying of the human growth hormone: how does nucleation control affect protein stability? J Pharm Sci. 109:254–263.
  • Oddone I, Barresi AA, Pisano R. 2017. Influence of controlled ice nucleation on the freeze-drying of pharmaceutical products: the secondary drying step. Int J Pharm. 524:134–140.
  • Oddone I, Fulginiti D, Barresi AA, Grassini S, Pisano R. 2015. Non-invasive temperature monitoring in freeze drying: control of freezing as a case study. Drying Technol. 33:1621–1630.
  • Oddone I, Van Bockstal PJ, De Beer T, Pisano R. 2016. Impact of vacuum-induced surface freezing on inter- and intra-vial heterogeneity. Eur J Pharm Biopharm. 103:167–178.
  • Ohori R, Akita T, Yamashita C. 2018. Effect of temperature ramp rate during the primary drying process on the properties of amorphous-based lyophilized cake, Part 2: successful lyophilization by adopting a fast ramp rate during primary drying in protein formulations. Eur J Pharm Biopharm. 130:83–95.
  • Ohori R, Yamashita C. 2017. Effects of temperature ramp rate during the primary drying process on the properties of amorphous-based lyophilized cake, Part 1: cake characterization, collapse temperature and drying behavior. J Drug Deliv Sci Technol. 39:131–139.
  • Patel SM, Doen T, Pikal MJ. 2010. Determination of end point of primary drying in freeze-drying process control. AAPS PharmSciTech. 11:73–84.
  • Pikal MJ. 1985. Use of laboratory data in freeze drying process design: heat and mass transfer coefficients and the computer simulation of freeze drying. J Parenter Sci Technol. 39:115–139.
  • Pikal MJ, Bogner R, Mudhivarthi V, Sharma P, Sane P. 2016. Freeze-drying process development and scale-up: scale-up of edge vial versus center vial heat transfer coefficients, Kv. J Pharm Sci. 105:3333–3343.
  • Pikal MJ, Roy ML, Shah S. 1984. Mass and heat transfer in vial freeze-drying of pharmaceuticals: role of the vial. J Pharm Sci. 73:1224–1237.
  • Pikal MJ, Shah S. 1990. The collapse temperature in freeze drying: dependence on measurement methodology and rate of water removal from the glassy phase. Int J Pharm. 62:165–186.
  • Pisano R, Arsiccio A, Nakagawa K, Barresi AA. 2019. Tuning, measurement and prediction of the impact of freezing on product morphology: a step toward improved design of freeze-drying cycles. Drying Technol. 37:579–599.
  • Pisano R, Barresi AA, Capozzi LC, Novajra G, Oddone I, Vitale-Brovarone C. 2017. Characterization of the mass transfer of lyophilized products based on X-ray micro-computed tomography images. Drying Technol. 35:933–938.
  • Pisano R, Fissore D, Barresi AA. 2012. Quality by design in the secondary drying step of a freeze-drying process. Drying Technol. 30:1307–1316.
  • Pisano R, Fissore D, Barresi AA. 2016. Noninvasive monitoring of a freeze-drying process for tert-butanol/water cosolvent-based formulations. Ind Eng Chem Res. 55:5670–5680.
  • Pisano R, Fissore D, Barresi AA. 2011. Heat transfer in freeze-drying apparatus. In: Dos Santos Bernardes MA, editor. Developments in heat transfer. InTech.
  • Pisano R, Fissore D, Barresi AA, Brayard P, Chouvenc P, Woinet B. 2013a. Quality by design: optimization of a freeze-drying cycle via design space in case of heterogeneous drying behavior and influence of the freezing protocol. Pharm Dev Technol. 18:280–295.
  • Pisano R, Fissore D, Barresi AA, Rastelli M. 2013b. Quality by design: scale-up of freeze-drying cycles in pharmaceutical industry. AAPS PharmSciTech. 14:1137–1149.
  • Rambhatla S, Obert JP, Luthra S, Bhugra C, Pikal MJ. 2005. Cake shrinkage during freeze drying: a combined experimental and theoretical study. Pharm Dev Technol. 10:33–40.
  • Rambhatla S, Tchessalov S, Pikal MJ. 2006. Heat and mass transfer scale-up issues during freeze-drying, III: control and characterization of dryer differences via operational qualification tests. AAPS PharmSciTech. 7:E61–E70.
  • Rexroad J, Wiethoff CM, Jones LS, Middaugh CR. 2002. Lyophilization and the thermostability of vaccines. Cell Preserv Technol. 1:91–104.
  • Roos YH. 1997. Frozen state transitions in relation to freeze drying. J Therm Anal. 48:535–544.
  • Scutellà B, Passot S, Bourlés E, Fonseca F, Tréléa IC. 2017a. How vial geometry variability influences heat transfer and product temperature during freeze-drying. J Pharm Sci. 106:770–778.
  • Scutellà B, Trelea IC, Bourlès E, Fonseca F, Passot S. 2018b. Determination of the dried product resistance variability and its influence on the product temperature in pharmaceutical freeze-drying. Eur J Pharm Biopharm. 128:379–388.
  • Tang X, Nail SL, Pikal MJ. 2006. Evaluation of manometric temperature measurement, a process analytical technology tool for freeze-drying: part I, product temperature measurement. AAPS PharmSciTech. 7:E14.
  • Tang X, Pikal MJ. 2004. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res. 21:191–200.
  • Van Bockstal PJ, Mortier STFC, Corver J, Nopens I, Gernaey KV, De Beer T. 2017. Quantitative risk assessment via uncertainty analysis in combination with error propagation for the determination of the dynamic Design Space of the primary drying step during freeze-drying. Eur J Pharm Biopharm. 121:32–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.